21.18
price down icon2.74%   -0.5611
 
loading

Biohaven Ltd Aktie (BHVN) Neueste Nachrichten

pulisher
07:06 AM

Biohaven secures $600m financing as it awaits FDA prodrug decision - Yahoo

07:06 AM
pulisher
02:09 AM

Biohaven (NYSE:BHVN) Given New $57.00 Price Target at Robert W. Baird - Defense World

02:09 AM
pulisher
Apr 28, 2025

BHVN’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com

Apr 28, 2025
pulisher
Apr 28, 2025

Why BioHaven Stock Is Soaring Today - Mitrade

Apr 28, 2025
pulisher
Apr 28, 2025

A Guide To The Risks Of Investing In Biohaven Ltd (BHVN) - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven Ltd. Receives Buy Rating Amid Strategic EU Resubmission and Positive FDA Outlook - TipRanks

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven secures up to $600 million from Oberland Capital - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven Rallies On Heels Of $600M Funding Agreement With OberlandBiohaven (NYSE:BHVN) - Benzinga

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven announces investment of up to $600M - Hartford Business Journal

Apr 28, 2025
pulisher
Apr 28, 2025

Financial Analysis: Biohaven Ltd (BHVN)’s Ratios Unveil Key Insights - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven (BHVN) Secures Up to $600M Investment from Oberland Cap - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven Announces Investment by Oberland Capital - Contract Pharma

Apr 28, 2025
pulisher
Apr 28, 2025

Stride To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven Ltd. Secures $600M Investment from Oberland Capital - TipRanks

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven Announces Investment Up To $600 Mln By Oberland Capital - marketscreener.com

Apr 28, 2025
pulisher
Apr 28, 2025

Why Biohaven Ltd. Shares Are Tumbling - TipRanks

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven Lands Major $600 Million Deal With Oberland Capital - Finimize

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven Signs Deal for Investment of up to $600 Million by Oberland; Shares up Pre-Bell - marketscreener.com

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital - StreetInsider

Apr 28, 2025
pulisher
Apr 28, 2025

Biohaven Announces Investment up to $600 Million by Oberland Capital - PR Newswire

Apr 28, 2025
pulisher
Apr 27, 2025

Biohaven (NYSE:BHVN) Upgraded at William Blair - Defense World

Apr 27, 2025
pulisher
Apr 27, 2025

Biohaven (BHVN) Faces Market Setback After EMA Withdrawal - GuruFocus

Apr 27, 2025
pulisher
Apr 27, 2025

Wells Fargo & Company MN Increases Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

Biohaven share price undervaluing pipeline potential, says RBC Capital - Yahoo Finance

Apr 26, 2025
pulisher
Apr 25, 2025

Why Biohaven Stock Plummeted by More Than 15% Today - Yahoo Finance

Apr 25, 2025
pulisher
Apr 25, 2025

Biohaven stock slides on withdrawal of European marketing application - BioPharma Dive

Apr 25, 2025
pulisher
Apr 25, 2025

Biohaven (BHVN) Withdraws EMA Application, U.S. Approval Crucial - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Biohaven (BHVN) Withdraws Troriluzole Application in Europe, Foc - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Biohaven (BHVN) Stock Drops After Withdrawal of EU Drug Applicat - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Biohaven Ltd. Stock Faces Turbulence Amid Strategic Shifts - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

Biohaven Ltd (NYSE:BHVN) Shares Surged 25.27% In A Week – But Will They Keep Going Up? - Marketing Sentinel

Apr 25, 2025
pulisher
Apr 25, 2025

Biohaven Pharma stock tumbles after withdrawal of Dazluma application in EU - Investing.com UK

Apr 25, 2025
pulisher
Apr 25, 2025

BHVN’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Biohaven Ltd (BHVN) Performance and Fundamentals Dashboard tells a completely different story - Sete News

Apr 25, 2025
pulisher
Apr 24, 2025

Biohaven Ltd [BHVN] Director makes an insider purchase of 32,700 shares worth 1.0 million. - knoxdaily.com

Apr 24, 2025
pulisher
Apr 23, 2025

Jim Cramer Says Biohaven (BHVN) Is “Too Cheap” and He’s a Buyer at $21 - Insider Monkey

Apr 23, 2025
pulisher
Apr 23, 2025

Is Biohaven Ltd. (BHVN) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Insider Monkey

Apr 23, 2025
pulisher
Apr 23, 2025

Stock Traders Buy Large Volume of Biohaven Call Options (NYSE:BHVN) - Defense World

Apr 23, 2025
pulisher
Apr 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd.BHVN - PR Newswire

Apr 22, 2025
pulisher
Apr 22, 2025

Biohaven Ltd (BHVN)’s stock rises to 20.55 per share - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Biohaven Ltd (NYSE: BHVN) Shocks Wall Street This Week With A 0.88% Stock Price Incline - Marketing Sentinel

Apr 22, 2025
pulisher
Apr 19, 2025

Biohaven Pharmaceutical : Announces Pricing Of $250 Million Public Offering Of Common Shares - marketscreener.com

Apr 19, 2025
pulisher
Apr 18, 2025

LPL Financial LLC Raises Holdings in Biohaven Ltd. (NYSE:BHVN) - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Q1 Earnings Estimate for Biohaven Issued By Leerink Partnrs - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm - Finansavisen

Apr 15, 2025
pulisher
Apr 15, 2025

Biohaven Ltd. (NYSE:BHVN) Shares Acquired by Alliancebernstein L.P. - Defense World

Apr 15, 2025
pulisher
Apr 13, 2025

Biohaven Ltd. (NYSE:BHVN) Shares Sold by Franklin Resources Inc. - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - GlobeNewswire Inc.

Apr 12, 2025
pulisher
Apr 12, 2025

Contrasting Biohaven (NYSE:BHVN) & Ampio Pharmaceuticals (NYSE:AMPE) - Defense World

Apr 12, 2025
pulisher
Apr 08, 2025

Royalty Pharma expands board with Biohaven CEO appointment By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients - Benzinga

Apr 08, 2025
pulisher
Apr 07, 2025

Biohaven stock hits 52-week low at $17.33 amid market challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

Biohaven stock hits 52-week low at $17.33 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
Kapitalisierung:     |  Volumen (24h):